Screening and diagnosis

Classification and risk stratification

Perioperative care

Quality improvement

Patient education

Nonpharmacologic interventions

Therapeutic procedures

Respiratory support

Follow-up and surveillance

Specific circumstances

Preventative measures

Medical management

Surgical interventions

Inpatient care

Diagnostic procedures

Diagnostic investigations

Insufficient evidence to make a recommendation.

Strongly favor this test or intervention.

The TNM classification system is used to stage bone cancer specific to the appendicular skeleton, trunk, skull, and facial bones. To determine the stage, the system evaluates four critical inputs:

- Tumor Classification:
  - Tx: Primary tumor cannot be assessed
  - T0: No evidence of primary tumor
  - T1: Tumor <= 8 cm in greatest dimension
  - T2: Tumor > 8 cm in greatest dimension
  - T3: Discontinuous tumors in the primary bone site

- Lymph Node Classification:
  - Nx: Regional lymph nodes cannot be assessed
  - N0: No regional lymph node metastasis
  - N1: Regional lymph nodes metastases present

- Distant Metastasis:
  - M0: No distant metastasis
  - M1a: Metastasis confined to lung
  - M1b: Metastases in bones or other distant sites

- Histologic Grade:
  - Gx: Grade cannot be assessed
  - G1: Well differentiated
  - G2: Moderately differentiated
  - G3: Poorly differentiated
  - G4: Undifferentiated

Using these inputs, the system computes the cancer stage, which aids in determining prognosis and treatment. Here's how the classification maps to different stages:

- Stage IA is indicated by a tumor that is 8 cm or less (T1), with no lymph node involvement (N0), no distant metastasis (M0), and a histologic grade of G1 or G2.
- Stage IB involves a larger tumor (greater than 8 cm, T2), still with no lymph node spread (N0), no distant metastasis (M0), and the tumor is graded as well or moderately differentiated (G1 or G2).
- Stage IIA is characterized similarly to Stage IA but with a worse histologic grade (G3 or G4).
- Stage IIB encompasses a larger tumor (T2) with no lymph node spread (N0) and no distant metastasis (M0), but with a more aggressive histologic grade (G3 or G4).
- Stage III is applied to discontinuous tumors in the bone site (T3) that have not metastasized to the lymph nodes (N0) or beyond (M0), regardless of the histologic grade.
- Stage IVA includes any primary tumor size (T1, T2, T3) with no lymph node metastasis (N0) but with metastasis confined to the lung or other less extensive sites (M1a or M1b).
- Stage IVB involves scenarios where there is regional lymph node metastasis (N1) and can include various combinations of tumor size and distant metastasis presence, including more aggressive distant spread (M1b) across any histologic grade.

The system methodically combines these classifications to offer a stage outcome, which is crucial for clinical decisions and patient management.

The TNM classification for bone cancer (appendicular skeleton, trunk, skull, and facial bones) is a clinical staging system developed by the American Joint Committee on Cancer (AJCC). It is designed to stratify patients with bone cancer based on the extent of the disease, providing a standardized language for communication among clinicians and aiding in decision-making for treatment strategies.

The primary components of this classification system include three parameters: T (tumor size and extent), N (lymph node involvement), and M (metastasis). Each parameter is assigned a numerical value based on the severity or extent of the disease. 

The T category describes the size of the primary tumor and whether it has invaded nearby tissue. It is classified from T1 (tumor ≤8 cm in greatest dimension) to T3 (tumor >8 cm in greatest dimension or multiple discrete tumors). 

The N category indicates whether the cancer has spread to nearby lymph nodes. It is classified from N0 (no regional lymph node metastasis) to N1 (metastasis in regional lymph node(s)).

The M category describes whether the cancer has metastasized to other parts of the body. It is classified as M0 (no distant metastasis) or M1 (distant metastasis).

The combination of these three parameters forms the stage of the cancer, ranging from stage I (least advanced cancer) to stage IV (most advanced cancer). This classification system is crucial in determining the prognosis and guiding the treatment plan for patients with bone cancer.

TNM classification for bone cancer (appendicular skeleton, trunk, skull, and facial bones)

Chordoma

Guidelines

Key sources